PHYSICIAN ASSISTANT PRACTICE
SB0271 would substantially expand the independent practice authority of physician assistants in Illinois. The bill amends the Physician Assistant Practice Act of 1987 to allow physician assistants to prescribe, dispense, order, administer, and procure drugs and medical devices without delegation from a physician, and to practice without a written collaborative agreement in many circumstances. It also creates a new “optimal practice” pathway for physician assistants who submit a notarized attestation showing at least 250 hours of continuing education or training and 2,000 hours of clinical experience after national certification; those physician assistants would not need a written collaborative agreement to practice.
The bill also revises the rules governing physician assistants in hospitals, hospital affiliates, federally qualified health centers, and ambulatory surgical treatment centers, while making corresponding changes to the Illinois Controlled Substances Act. It updates definitions and disciplinary provisions, and it aligns controlled-substance registration rules so physician assistants can obtain mid-level practitioner controlled substances licenses and, under the bill’s expanded authority, prescribe Schedule II through V controlled substances without physician delegation. The measure preserves limits on operative surgery and does not authorize physician assistants to perform services reserved by law to physicians.
The general sentiment reflected by the bill text is one of professional expansion and modernization of physician assistant practice. Although there are no committee transcripts or recorded votes provided, the structure of the bill suggests a strong policy preference for reducing supervisory barriers and increasing access to care by allowing experienced physician assistants to practice more autonomously. The bill appears designed to recognize physician assistants as more independent clinicians, especially after substantial training and experience.
The main point of contention is likely to be the reduction or elimination of physician oversight. Supporters would likely view the bill as improving workforce flexibility, access to care, and efficiency in clinical settings, while opponents may be concerned about patient safety, the adequacy of training, and the loss of physician control over prescribing and clinical decision-making. The bill also changes long-standing collaboration and delegation requirements, which could affect hospitals, medical groups, physicians, and regulators responsible for credentialing, privileging, and discipline.
SB0271 would amend the Physician Assistant Practice Act of 1987 to remove or reduce several statutory requirements that currently tie physician assistant practice to physician delegation and written collaborative agreements. It would also amend the Illinois Controlled Substances Act to conform controlled-substance prescribing and registration provisions to the expanded authority granted to physician assistants. As a result, physician assistants would have broader statutory authority to practice, prescribe, and obtain controlled-substance registration, and the Department of Financial and Professional Regulation would need to administer new attestation, licensing, and rulemaking provisions.
No committee testimony or vote history is provided, so there is no recorded legislative debate to measure directly. Based on the bill’s content, the measure appears generally supportive of greater autonomy for physician assistants and likely reflects a reform-oriented, pro-workforce-expansion approach. The bill’s tone is permissive and deregulatory with respect to physician assistant practice, suggesting support from those favoring expanded access and opposition from those favoring physician-led supervision.
The central controversy is whether physician assistants should be allowed to practice and prescribe independently of physicians. Supporters are likely to argue that experienced physician assistants can safely provide care without a written collaborative agreement and that the bill would improve access, especially in underserved settings. Opponents are likely to focus on the loss of physician oversight, the expansion of controlled-substance prescribing authority, and whether the bill’s training-and-experience threshold is sufficient to justify independent practice. Additional concerns may involve hospital privileging, liability, and how the Department will verify compliance with the new attestation-based pathway.